Trini Tran
Family · Sugar Land, TXNPI 1477164846
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,325, more than ten times the $57 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$859
- Insulet Corporation$785
- Lilly USA, LLC$733
- Ascensia Diabetes Care US Inc.$640
- Amgen$413
- Novo Nordisk$296
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,339100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 64 | $859 |
| Insulet Corporation | 16 | $785 |
| Lilly USA, LLC | 32 | $733 |
| Ascensia Diabetes Care US Inc. | 36 | $640 |
| Amgen | 23 | $413 |
| Novo Nordisk | 18 | $296 |
| Embecta Corp. | 22 | $237 |
| Corcept Therapeutics | 12 | $234 |
| AbbVie | 16 | $226 |
| Bayer | 17 | $216 |
| AstraZeneca | 12 | $215 |
| Tandem Diabetes Care, Inc. | 9 | $213 |
| Sanofi-aventis U.S. LLC | 8 | $210 |
| Radius Health, Inc. | 8 | $164 |
| Mannkind Corporation | 8 | $136 |
| Cequr Corporation | 2 | $126 |
| Boehringer Ingelheim | 4 | $90 |
| Sequel Med Tech, LLC | 3 | $71 |
| BETA Bionics, Inc. | 4 | $53 |
| Antares Pharma, Inc. | 3 | $52 |
| IBSA Pharma Inc. | 3 | $50 |
| Merck | 2 | $35 |
| Globus Medical | 1 | $33 |
| UCB, Inc. | 1 | $29 |
| Amneal Pharmaceuticals LLC | 2 | $29 |
| Verity Pharmaceuticals Inc. | 1 | $28 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Alvogen Inc | 1 | $25 |
| Abbott | 1 | $23 |
| Therapeuticsmd, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| BD | 1 | $17 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
How this compares
$6,339 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Other family in Sugar Land
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.